Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04348123 | Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography | completed | N/A | 203 | Case Comprehensive Cancer CenterOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT05916378 | Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies | completed | — | 514 | Stanford UniversityOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07035275 | Effect of Patient-Anesthesiologist Gender Concordance and Analgesia Method on Postoperative Pain in Mastectomy Patients | completed | — | 120 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07040540 | Hemodynamic Effects of Intradermal Methylene Blue During Breast Surgery Under General Anesthesia | completed | — | 220 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT03218826 | PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 23 | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2026 | clinicaltrials |
| NCT03289364 | Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients | completed | N/A | 12 | Providence Health & ServicesOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT07553741 | Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients | completed | N/A | 27 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT03838549 | Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy in Prophylactic Indication(MRIMOP) | completed | N/A | 20 | University Hospital, MontpellierOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT06051331 | The Effect of Simulation-Based Breast Health Education on Breast Cancer Awareness and Breast Self-Examination Practices | completed | N/A | 46 | Hacettepe UniversityOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT00872625 | Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer | completed | Phase 1 | 26 | Centre Antoine LacassagneOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT02867423 | Hypofractionated Radiation by CyberKnife as a Mean of the Tumor Site's Radiation After Conventional Breast Radiation.(CYBERBOOST) | completed | N/A | 29 | Centre Antoine LacassagneOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT05890196 | Autologous Fat Grafting in Radiated Soft Tissue Reconstruction | completed | — | 10 | University of ChicagoOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT01027416 | Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients | completed | N/A | 59 | Roswell Park Cancer InstituteOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT03483012 | Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis | completed | Phase 2 | 6 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT04732598 | A Phase III Study of Bevacizumab and Paclitaxel in Combination With Atezolizumab as a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer(AMBITION) | completed | Phase 3 | 281 | Japanese Foundation for Cancer ResearchOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT02695121 | Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment | completed | — | 2,133,575 | AstraZenecaINDUSTRY | 3 | Apr 17, 2026 | clinicaltrials |
| NCT03495115 | Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening | completed | N/A | 460 | Beth Israel Deaconess Medical CenterOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT04085276 | Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment(TORCHLIGHT) | completed | Phase 3 | 531 | Shanghai Junshi Bioscience Co., Ltd.OTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT01553903 | Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not(OXYTAM) | completed | Phase 4 | 29 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT01612871 | Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer(MIRHO) | completed | Phase 4 | 39 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT02311959 | Therapeutic Nipple Sparing Mastectomy.(MAPAM-01) | completed | Phase 3 | 450 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT05609435 | Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer | completed | N/A | 104 | University of Wisconsin, MadisonOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT02630693 | Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer | completed | Phase 2 | 180 | Canadian Cancer Trials GroupNETWORK | 1 | Apr 13, 2026 | clinicaltrials |
| NCT02705859 | Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study)(Panther) | completed | Phase 1 | 26 | Cancer Trials IrelandNETWORK | 1 | Apr 13, 2026 | clinicaltrials |
| NCT02928978 | Ruxolitinib for Premalignant Breast Disease(TBCRC042) | completed | Phase 2 | 84 | Julie NangiaOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT03843346 | The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer | completed | — | 87 | Cancer Trials IrelandNETWORK | 1 | Apr 13, 2026 | clinicaltrials |
| NCT05263362 | An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)(STARLINGS) | completed | — | 775 | Erasmus Medical CenterOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07512063 | A Study of Real-World Treatment Patterns and Outcomes Among HR+/HER2- Metastatic Breast Cancer Patients Treated With First-Line CDK4/6 Inhibitors | completed | — | 480 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 13, 2026 | clinicaltrials |
| NCT03850873 | A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics | completed | Phase 1 | 40 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Apr 9, 2026 | clinicaltrials |
| NCT07519668 | Retrospective Evaluation of Ultrasound-assisted Tumor Surgery in Breast-conserving Therapy(MAC004) | completed | — | 273 | University Hospital TuebingenOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT07521397 | Pooled Analysis of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemotherapy: a Hellenic Cooperative Oncology Group (HeCOG) Study.(ΗE_10R/22) | completed | — | 5,358 | Hellenic Cooperative Oncology GroupOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT02595905 | Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases | completed | Phase 2 | 344 | National Cancer Institute (NCI)NIH | 2 | Apr 8, 2026 | clinicaltrials |
| NCT04081779 | Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study | completed | N/A | 261 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT07307911 | Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy(Co-Pa-N) | completed | Phase 2 | 50 | Damanhour UniversityOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT02129686 | A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients | completed | N/A | 57 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT06020573 | Evaluation of Safety and Performance of Intraoperative Detection of Light Signals During Electrosurgical Breast Cancer Resection | completed | N/A | 24 | Erbe Elektromedizin GmbHINDUSTRY | 1 | Apr 7, 2026 | clinicaltrials |
| NCT05394285 | A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer | completed | Phase 2 | 60 | Henan Cancer HospitalOTHER_GOV | 1 | Apr 6, 2026 | clinicaltrials |
| NCT05607017 | Losartan in Prevention of Radiation-Induced Heart Failure | completed | Early Phase 1 | 5 | Massachusetts General HospitalOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT07319767 | Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors | completed | — | 120 | Shanghai Zhongshan HospitalOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT07510997 | Perioperative Individually Tailored Psychological Intervention in Breast Cancer Surgery | completed | N/A | 40 | Rabin Medical CenterOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT06056843 | Handheld Ultrasound Device to Triage Women With a Positive Clinical Breast Examination by Trained Non-radiologists(PUD) | completed | N/A | 150 | International Agency for Research on CancerOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT06713681 | Trop2-targeting NIR-II Molecular Probe for Breast Cancer Precise Surgery(NIR-II) | completed | — | 59 | Yunnan Cancer HospitalOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT04721886 | Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer | completed | Early Phase 1 | 25 | Thomas Jefferson UniversityOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT04838756 | Mammography Screening With Artificial Intelligence (MASAI)(MASAI) | completed | N/A | 100,000 | Region SkaneOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT04877821 | The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC(NeoSACT) | completed | Phase 2 | 29 | Guangdong Provincial People's HospitalOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT04604561 | Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses | completed | — | 50 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT04841252 | Classification of Breast Masses Based on Visco-elastic Properties Using SAVE Method(SAVE) | completed | — | 266 | Mayo ClinicOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT06133465 | Pure Florid and Pleomorphic Lobular Carcinoma in Situ of the Breast: Towards an Increasingly Uniform Management | completed | — | 1,063 | Istituto Oncologico Veneto IRCCSOTHER | 1 | Apr 1, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Apr 30, 2026source: clinicaltrials